Ponte, L., Jerome, L., Hamilton, S., Mithoefer, M.C., Yazar-Klosinski, B.B., Vermetten, E. and Feduccia, A.A. (2021)
Mitchell J, Coker A, Yazar-Klosinski B. (2021)
Ponte, L., Jerome, L., Hamilton, S., Mithoefer, M.C., Yazar-Klosinski, B.B., Vermetten, E. and Feduccia, A.A. (2021)
Wang, J. B., Lin, J., Bedrosian, L., Coker, A., Jerome, I., Feduccia, A., Lilienstein, A., Harrison, C., Heimler, E., Mithoefer, M., Mithoefer, A., Ot’alora G., M., Poulter, B., Carlin, S., Matthews, R., Yazar-Klosinski, B., Emerson, A., & Doblin, R. (2021)
Mitchell, J.M., Bogenschutz, M., Lilienstein, A. et al. (2021)
Jerome, L., Feduccia, A. A., Wang, J. B., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2020)
The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD
Marseille, E., Kahn, J. G., Yazar-Klosinski, B., & Doblin, R. (2020)
Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy
Feduccia, A. A., Jerome, L., Mithoefer, M. C., & Holland, J. (2020)
MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study.
Wolfson, P. E., Andries, J., Feduccia, A. A., Jerome, L., Wang, J. B., Williams, E., … & Emerson, A. (2020)
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.
Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020)
MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial
Candice M. Monson, Anne C. Wagner, Ann T. Mithoefer, Rachel E. Liebman, Allison A. Feduccia, Lisa Jerome, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin & Michael C. Mithoefer (2020)
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
Feduccia, A.A., Jerome, L., Mithoefer, A., Yazar-Klosinski, B., Emerson, A., Doblin, R. (2019)
Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R. (2019)
Hake HS, Davis JKP, Wood RR, Tanner MK, Loetz EC, Sanchez A, Ostrovskyy M, Oleson EB, Grigsby J, Doblin R, Greenwood BN. (2019)
The past and future of psychedelic science: an introduction to this issue.
Doblin, R. E., Christiansen, M., Jerome, L., & Burge, B. (2019)
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Mithoefer, M.C., Feduccia, A.A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Doblin, R. (2019)
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.
Ot’alora, G, M., Grigsby, J., Poulter, B., Van Derveer, J. W., Giron, S. G., Jerome, L., Feduccia, A., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Mithoefer, M., Doblin, R. (2018)
Reduction in Social Anxiety After MDMA-Assisted Psychotherapy with Autistic Adults: A Randomized, Double-blind, Placebo-Controlled Pilot Study.
Danforth, A.L., Grob, C.S., Struble, C., Feduccia, A.A., Walker, N., Jerome, L., Yazar-Klosinski, B., Emerson, A. (2018)
3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy for Post-Traumatic Stress Disorder in Military Veterans, Firefighters, and Police Officers: A Randomised, Double-Blind, Dose-Response, Phase 2 Clinical Trial.
Mithoefer, M. C., Mithoefer, Mithoefer, A. T., Feduccia, A. A., Jerome, L., Wagner, M., Wymer, J., Holland, J., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Doblin, R. (2018)
Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study
Noller, G, Frampton, C, Yazar-Klosinski, B (2017)
Potential Psychiatric Uses for MDMA.
Yazar‐Klosinski, B., Mithoefer, M. (2017)
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults.
Danforth A, Struble C, Yazar-Klosinski B, Grob C (2016)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, Brenneisen R (2014)
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
Mithoefer M, Wagner M, Mithoefer A, Jerome L, Martin S, Yazar-Klosinski B, Michel Y, Brewerton T, Doblin R (2013)
Can MDMA Play a Role in the Treatment of Substance Abuse?
Jerome L, Schuster S, Yazar-Klosinski B (2013)
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.
Mithoefer M, Wagner M, Mithoefer A, Jerome L, Doblin R (2010)
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
Sumnall H, Cole J, Jerome L (2006)
The effects of stereotype threat on cognitive function in ecstasy users.
Cole, J. C., Michailidou, K., Jerome, L., & Sumnall, H. R. (2006)